Dataset from Assessment of Physical Functioning and Handling of Spiolto® Respimat® in Patients With Chronic Obstructive Pulmonary Disease (COPD) Requiring Long-acting Dual Bronchodilation in Routine Clinical Practice

The primary objective of this Non Interventional Study is to measure changes in physical functioning, a surrogate for physical activity and exercise capacity, in COPD patients on treatment with Spiolto® Respimat® in routine daily treatment after approximately 6 weeks. A secondary objective is to evaluate the patient's general condition (physician's evaluation) from Visit 1 (baseline visit at the start of the study) to Visit 2 (final visit at the end of the study, approx. 6 weeks after Visit 1), as well as patient satisfaction with Spiolto® Respimat® at Visit 2.

本非干预性研究（Non Interventional Study）的主要目的为，评估约6周常规日常治疗期间，接受Spiolto® Respimat®治疗的慢性阻塞性肺疾病（Chronic Obstructive Pulmonary Disease, COPD）患者的躯体功能变化——该躯体功能可作为体力活动与运动能力的替代指标。本研究的次要目的为：评估患者从访视1（研究启动时的基线访视）至访视2（研究结束时的末次访视，距访视1约6周）的整体状况（由医师进行评估），同时评估访视2时患者对Spiolto® Respimat®的用药满意度。